Related Experiment Videos
Control of capripoxvirus infections
1Institute for Animal Health, Pirbright Laboratory, Surrey, UK.
Vaccine
|October 1, 1993
Summary
Capripoxviruses cause severe animal pox diseases, challenging to control without vaccines. Live attenuated vaccines offer lifelong protection, and recombinant vaccines show promise for future control strategies.
Area of Science:
- Veterinary Virology
- Animal Health
- Infectious Diseases
Background:
- Capripoxviruses are responsible for severe animal pox diseases, including sheep pox, goat pox, and lumpy skin disease.
- These diseases are epidemiologically distinct but share mechanical transmission by biting insects, making control difficult in endemic regions without vaccination.
- Lumpy skin disease poses a significant threat due to its potential to spread beyond current boundaries.
Purpose of the Study:
- To review the epidemiology and control of capripoxvirus infections.
- To highlight the efficacy of live attenuated vaccines in stimulating cell-mediated immunity.
- To discuss the potential of capripoxviruses as vector vaccines and the future of recombinant vaccine development.
Main Methods:
- Review of epidemiological data on capripoxvirus diseases.
- Analysis of vaccine-induced immunity, focusing on cell-mediated responses.
- Evaluation of the potential for capripoxviruses as vectors for recombinant vaccines.
Main Results:
- Live attenuated vaccines provide robust, long-lasting protection against capripoxvirus infections.
- Cell-mediated immunity is crucial for vaccine efficacy.
- Capripoxviruses demonstrate significant potential for use in developing novel recombinant vaccines.
Conclusions:
- Effective control of capripoxvirus diseases relies heavily on vaccination.
- Recent advancements in vaccine technology, particularly recombinant vaccines, offer promising solutions for future disease management.
- The development of capripoxvirus-based vector vaccines is an area of active and promising research.